Article
Increased genetic and phenotypic stability of a promising live-attenuated respiratory syncytial virus vaccine candidate by reverse genetics.
Journal of virology - 1 Oct 2012
Luongo Cindy, Winter Christine C, Collins Peter L, Buchholz Ursula J
Abstract excerpt
Human respiratory syncytial virus (RSV) is the most important viral cause of serious pediatric respiratory illness worldwide. Currently, the most promising live-attenuated vaccine candidate is a temperature-sensitive (ts) cDNA-derived virus named rA2cp248/404/1030ΔSH, in reference to its set of attenuating mutations. In a previous clinical study, more than one-third of postvaccination nasal wash isolates...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
